Nikolaos Pyrpyris, Kyriakos Dimitriadis, Eirini Beneki, Panagiotis Iliakis, Stergios Soulaidopoulos, Panagiotis Tsioufis, Elena Adamopoulou, Alexandros Kasiakogias, Athanasios Sakalidis, George Koutsopoulos, Konstantina Aggeli, Konstantinos Tsioufis
Low Density Lipoprotein (LDL) and oxidized LDL (oxLDL) are major contributors to atherogenesis, as endogenous antigens, via several receptors such as LOX 1. A PubMed search was conducted in order to identify relevant articles regarding LOX-1's role in the atherosclerosis, diagnosis, prognostic use and molecules that could be used for therapy. The references of the manuscripts obtained were also reviewed, in order to find additional relevant bibliography. LOX-1 is a lectin-like pattern recognition receptor, mostly expressed in endothelial cells (ECs) which can bind a variety of molecules, including oxLDL and C-reactive protein (CRP)...
October 4, 2023: Current Problems in Cardiology